(Image from the Office of Underground Storage Tanks, US Environmental Protection Agency.)
The reform of the Toxic Substances Control Act (TSCA) is likely to be taken up by Congress next year. Among the driving forces for amending the TSCA is recognition of our current weakness in dealing with chemicals that were already on the market at the time of TSCA's original passage in 1976 (Renn and Elliott, 2010) . Among these grandfathered compounds is methyl tertiary-butyl ether (MTBE), an oxygenate previously used primarily as an anti-knock compound in gasoline. When use became widespread, more than 100 million Americans were exposed to MTBE before adequate knowledge of toxicity and exposure was available. The history of MTBE clearly demonstrates the need to avoid similar experiences in the future. The picture depicts one major exposure pathway by which MTBE can reach drinking water: a leaking underground gasoline storage tank.
Advanced exposure assessment is vital to improving the Toxic Substances Control Act. 
MTBE

BACKGROUND
Methyl tertiary-butyl ether (MTBE) provides a case study of the importance of exposure assessment to amending the provisions of the Toxic Substances Control Act (TSCA). MTBE had long been in use for a variety of different purposes prior to its being chosen to supply the oxygenate required for much of US gasoline. Under the 1990 Clean Air Act amendments, oxygenates were required in the parts of the United States that failed to meet the carbon monoxide (CO) health air standard, at a level in gasoline equivalent to 15% MTBE (by volume), primarily during the winter. In areas of the country failing to meet the ozone health air standard, oxygenates were also used as part of the summertime gasoline blend at a level equivalent to 11.1% MTBE. As a result, MTBE rapidly became one of the leading worldwide commodity chemicals.
The major investment to gear up MTBE production was made before all the essential toxicological studies had been reported. In 1992, initial industry-funded long-term laboratory animal studies required by the TSCA Interagency Testing Committee reported renal, hepatic, and testicular cancers in different species and sexes under study (Bird et al., 1997) . A subsequent Italian study confirmed the testicular cancers and also showed an increase in rat lymphohematopoietic cancers (Belpoggi et al., 1997) . The recent International Agency for Research on Cancer categorization of a major MTBE metabolite, formaldehyde, as a known human leukemogen is consistent with this animal finding. Nonspecific symptoms were also attributed to MTBE, a phenomenon that was partially replicated in controlled human exposure studies, but only in individuals claiming to be symptomatic (Fiedler et al., 2000) . In addition, significant groundwater contamination occurred, which was a deciding factor in the eventual Environmental Protection Agency decision to phase out MTBE usage, particularly because cleanup of MTBE-contaminated groundwater is costly. But the proposal to phase out MTBE occurred only after a recurrent series of expert panels convened by the EPA, the National Academies of Science, the Office of Science and Technology Policy, various states, and the Health Effects Institute, all of which requested additional information (Davis and Farland, 2001; Erdal and Goldstein, 2000) .
Northern New Jersey and Alaska provide two examples of the failure to consider exposure in relation to potential risks and benefits. The allowable 8-hour CO exposure level was based primarily on avoiding effects in individuals with arteriosclerotic heart disease (ASHD) in whom exposure was likely to lead to an increased risk of anginal attacks. Northern New Jersey exceeded the 8-hour CO standard at one monitoring station near the Lincoln Tunnel, which resulted in a regulatory requirement to use MTBE. More than 4 million residents of northern New Jersey were exposed to MTBE, of whom few, if any, were likely to be exposed for 8 hours to CO at the Lincoln Tunnel. Similarly, in Anchorage no exposure estimates were made of the number of individuals with pre-existing ASHD who were outdoors for 8 hours during the Alaskan winter, specifically in the CO exceedance area. The absurdity of such a scenario, along with the great outcry over nonspecific symptoms attributed to MTBE, contributed to Alaska's being officially excused from the use of MTBE.
IMPACT AND IMPLICATIONS FOR EXPOSURE SCIENCE
One of the forces driving consideration of whether and how to amend the TSCA is the recent promulgation by the European Union of the Registration, Evaluation, Authorisation, and Restriction of Chemical Substances (REACH) legislation (http:// This Exposure Science Digest is sponsored by the International Society of Exposure Science (www.isesweb.org) in celebration of its 20th anniversary.
ec.europa.eu/environment/chemicals/reach/reach_intro.htm). This comprehensive approach to regulating chemicals remains a work in progress. But its tiered methodology has a much greater reliance on exposure assessment than does the TSCA. Exposure is considered in multiple steps in the REACH registration process (Williams et al., 2009) . The extent of exposure assessment varies, depending on the tonnage released and the hazard of the agent. Industry is required to develop exposure scenarios based on life-cycle phases, including for uses recommended or anticipated by downstream purchasers. Exposure levels are estimated for different populations and for different potential environmental targets.
The "precautionary principle," which served as a rationale for REACH and is part of the argument for amending the TSCA, is highly pertinent to the MTBE issue. A major tenet of the precautionary principle is shifting of the burden of proof such that safety must be shown by the manufacturer prior to marketing, rather than requiring governmental agencies to demonstrate that the agent is harmful after its use. In the case of MTBE, had the burden of proof been on the manufacturer to demonstrate safety under all exposure scenarios, it is unlikely to have been marketed. However, once the investment had been made, the forces at work under a regulatory approach that was particularly weak for existing chemicals made it difficult to remove the agent from the gasoline supply. If MTBE had been a new chemical, it is unlikely that it would be accepted for marketing to the general public if premarketing tests showed cancer in both rats and mice in multiple organs and in multiple studies. Putting any substance in gasoline is the most effective means of causing the maximum number of Americans to be exposed. Hence, such a pathway requires a cautious early assessment.
MTBE also provides a good example of the value of using exposure scenarios to predict potential problems. Drinkingwater contamination was eminently predictable given the frequency of leaking underground gasoline storage tanks, the greater solubility in groundwater of an oxygenate as compared with usual gasoline hydrocarbons, the lack of natural bacterial decomposition, and the exceptional extent to which trace levels of MTBE make water unpalatable. In retrospect, a rigorous approach to analysis of exposure across all pathways and routes would probably have hindered the rapid adoption of MTBE as a major additive to gasoline. Delay until at least the full toxicological appraisal was completed not only would have protected public health and the environment but would also have been beneficial to the petrochemical industry, which has had to write off major investments.
Key to improving the TSCA is better predictive toxicology and exposure science as part of a holistic assessment of all uses and exposure pathways. It has been disappointing that two major initiatives to increase the toxicological and exposure data base-the High Production Volume Initiative and REACH-have led to relatively little governmental investment in improving toxicological or exposure science despite the imposition of major costs to perform the required studies. To achieve better protection of the public against the threat to the environment and to human health posed by chemicals, it is necessary to have both laws that force a comprehensive approach to assessing risks and science that can readily predict and detect the potential for adverse exposures and effects.
